Ask Hematologist | Understand Hematology
Everything you need to know about blood disorders
Erythropoiesis-stimulating medicines (ESAs) are synthetic forms of erythropoietin, a natural hormone produced primarily by the kidneys and, to a lesser extent, by the liver. The erythropoietin gene, located on chromosome 7 (7q21), regulates the production of red blood cells (RBCs) in the bone marrow. When oxygen levels fall, the kidney’s peritubular interstitial cells release erythropoietin, which stimulates erythroid progenitor cells […]
Read more
New hematology drugs have transformed the treatment landscape of blood cancers and other hematologic disorders over the past two decades. Advances in the molecular understanding of hematologic malignancies have identified multiple therapeutic targets, leading to the rapid development and approval of new hematology drugs, including targeted therapies, immunotherapies, and cellular treatments. These new hematology drugs have significantly improved patient outcomes, […]
Read more